Meds & supplements › Fibrinogen
Medicine · Human Blood Coagulation Factor
Fibrinogen
TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such…
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- Limitations for Use TachoSil cannot safely or effectively be used in place of sutures or other form of mechanical ligation for the treatment of major arterial or venous bleeding.
- Not for use in children under one month of age.
- Do not take if
- RIASTAP is contraindicated in patients with known anaphylactic or severe systemic reactions to human plasma-derived products.
What it is used for
RIASTAP ®, Fibrinogen Concentrate (Human) is a human blood coagulation factor indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
Side effects, and when to stop
The most serious adverse reactions reported in clinical studies or through postmarketing surveillance following RIASTAP treatment are thromboembolic episodes, including myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis, and allergic-anaphylactic reactions.
The most common adverse reactions observed in more than one subject in clinical trials (frequency >1%) were fever and headache.
Who should not take it
RIASTAP is contraindicated in patients with known anaphylactic or severe systemic reactions to human plasma-derived products.
Storing it
- When stored at temperatures of 2-8°C (36-46°F), RIASTAP is stable for the period indicated by the expiration date on the carton and vial label (up to 60 months). Do not use RIASTAP beyond the expiration date.
- Keep RIASTAP in its original carton until ready to use.
- Do not freeze. Protect from light.
- Discard partially used vials.
2 dosage and administration
For intravenous use only.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Fibrinogen; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/fibrinogen
- APA 7th
sofidex. (2026, August 2). Fibrinogen. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/fibrinogen
- AMA 11th
Fibrinogen. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/fibrinogen
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.